Blockade of CB1 activation attenuates obesity by affecting multiple areas including leptin signaling, white adipose tissue browning, gut microbiota interactions, and reducing inflammation (5, 6, 8, 9, 18, 36). The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.